PATH Biotech

PATH is a global health non-profit organization and product development partnership that accelerates health equity through innovation and cross-sector collaboration. The organization works with public and private partners to develop and scale vaccines, drugs, diagnostics, and devices specifically designed for low-resource settings. PATH has been instrumental in the development of the MenAfriVac vaccine for meningitis A and the RTS,S/AS01 malaria vaccine. Their business model involves de-risking early-stage technologies and facilitating technology transfers to manufacturers in emerging markets to ensure affordable access to life-saving interventions.